Cva Family Office, LLC Eli Lilly & CO Transaction History

Cva Family Office, LLC

$606 Million
Q3 2024

A detailed history of Cva Family Office, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Cva Family Office, LLC holds 2,609 shares of LLY stock, worth $2.08 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

2,609

Previous 2,549 2.35%

Holding current value

$2.08 Million

Previous $2.31 Million 0.17%

% of portfolio

0.38%

Previous 0.42%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$772.14 - $960.02 $46,328 - $57,601	60 Added 2.35%	2,609 $2.31 Million
Q2 2024 Jul 09, 2024	BUY	$724.87 - $909.04 $23,920 - $29,998	33 Added 1.31%	2,549 $2.31 Million
Q1 2024 Apr 10, 2024	BUY	$592.2 - $792.28 $3,553 - $4,753	6 Added 0.24%	2,516 $1.96 Million
Q3 2023 Oct 11, 2023	BUY	$434.7 - $599.3 $39,992 - $55,135	92 Added 3.8%	2,510 $1.35 Million
Q2 2023 Jul 10, 2023	BUY	$350.74 - $468.98 $30,865 - $41,270	88 Added 3.78%	2,418 $1.13 Million
Q1 2023 Apr 26, 2023	SELL	$310.63 - $364.82 $74,861 - $87,921	-241 Reduced 9.37%	2,330 $800,000
Q4 2022 Feb 21, 2023	BUY	$321.55 - $374.67 $53,377 - $62,195	166 Added 6.9%	2,571 $940,000
Q3 2022 Nov 22, 2022	BUY	$296.48 - $337.87 $16,306 - $18,582	55 Added 2.34%	2,405 $778,000
Q2 2022 Jul 11, 2022	BUY	$278.73 - $327.27 $19,232 - $22,581	69 Added 3.02%	2,350 $762,000
Q1 2022 Apr 22, 2022	BUY	$234.69 - $291.66 $21,122 - $26,249	90 Added 4.11%	2,281 $653,000
Q4 2021 Jan 25, 2022	BUY	$224.85 - $279.04 $248,459 - $308,339	1,105 Added 101.75%	2,191 $605,000
Q3 2021 Oct 12, 2021	SELL	$221.6 - $272.71 $233,788 - $287,709	-1,055 Reduced 49.28%	1,086 $161,000
Q2 2021 Jul 13, 2021	BUY	$180.55 - $233.54 $44,234 - $57,217	245 Added 12.92%	2,141 $491,000
Q1 2021 Apr 14, 2021	BUY	$164.32 - $212.72 $83,803 - $108,487	510 Added 36.8%	1,896 $354,000
Q4 2020 Jan 15, 2021	BUY	$130.46 - $172.63 $39,138 - $51,789	300 Added 27.62%	1,386 $234,000
Q3 2020 Oct 27, 2020	SELL	$146.22 - $169.13 $2,778 - $3,213	-19 Reduced 1.72%	1,086 $161,000
Q1 2020 May 28, 2020	SELL	$119.05 - $147.35 $380,960 - $471,520	-3,200 Reduced 74.33%	1,105 $153,000
Q4 2019 Feb 18, 2020	BUY	$106.92 - $132.43 $460,290 - $570,111	4,305 New	4,305 $566,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cva Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cva Family Office, LLC with notifications on news.

Account

Cva Family Office, LLC Eli Lilly & CO Transaction History